A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression

NCT01814085 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Escitalopram

Sponsor

Xian-Janssen Pharmaceutical Ltd.